{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:30:59Z","timestamp":1787027459790,"version":"build-2736575974"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontierspartnerships.org"],"crossmark-restriction":true},"short-container-title":["Transpl. Int."],"abstract":"<jats:p>BK polyomavirus (BKPyV) DNAemia remains a major complication in kidney transplantation (KT), requiring nuanced adjustments to immunosuppressive regimens to control viral replication while minimizing rejection risk. This retrospective multicenter cohort study included 8,027 KT recipients, of whom 1,102 developed BKPyV-DNAemia within the first year. Among them, 927 patients with complete therapeutic drug monitoring (TDM) data were categorized into three groups based on post- BKPyV-DNAemia immunosuppressive strategies: mycophenolic acid (MPA) control, sirolimus, and leflunomide. Multivariate logistic regression and Cox analyses identified risk factors for BKPyV-DNAemia treatment failure, acute rejection, and graft loss. Tacrolimus trough levels below 5\u00a0ng\/mL and complete withdrawal of calcineurin inhibitors (CNIs) significantly increased rejection risk (OR = 2.65, P = 0.033). Maintaining tacrolimus levels between 5 and 7\u00a0ng\/mL was associated with optimal viral control and lower rejection rates. Leflunomide substitution reduced BKPyV burden but increased rejection risk (OR = 2.14, P &amp;lt; 0.001). Sirolimus-based regimens with CNI withdrawal led to the highest rejection risk (OR = 6.00, P = 0.044) and a trend toward increased graft failure (HR = 4.37, P = 0.07). A tacrolimus target of \u22655\u00a0ng\/mL emerged as optimal for balancing BKPyV-DNAemia suppression and long-term graft survival. While leflunomide is effective for viral control, its immunological risks warrant careful patient selection and monitoring.<\/jats:p>","DOI":"10.3389\/ti.2025.14738","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T06:00:41Z","timestamp":1752732041000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Risk Prediction and Management of BKPyV-DNAemia in Kidney Transplant Recipients: A Multicenter Analysis of Immunosuppressive Strategies"],"prefix":"10.3389","volume":"38","author":[{"given":"Jin-Myung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Eun","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahram","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngmin","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyo Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Berm","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunwook","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangil","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"471","DOI":"10.2215\/CJN.05021107","article-title":"Kidney Transplantation as Primary Therapy for End-Stage Renal Disease: A National Kidney Foundation\/Kidney Disease Outcomes Quality Initiative (NKF\/KDOQITM) Conference","volume":"3","author":"Abecassis","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1111\/j.1600-6143.2011.03686.x","article-title":"Systematic Review: Kidney Transplantation Compared with Dialysis in Clinically Relevant Outcomes","volume":"11","author":"Tonelli","year":"2011","journal-title":"Am J Transpl"},{"key":"B3","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1503\/cmaj.091661","article-title":"Predicting Potential Survival Benefit of Renal Transplantation in Patients with Chronic Kidney Disease","volume":"182","author":"van Walraven","year":"2010","journal-title":"Cmaj"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1111\/ajt.16463","article-title":"Long-term Kidney Transplant Graft Survival-Making Progress when Most Needed","volume":"21","author":"Poggio","year":"2021","journal-title":"Am J Transpl"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1097\/TP.0b013e3182007be2","article-title":"Anti-BK Virus Mechanisms of Sirolimus and Leflunomide Alone and in Combination: Toward a New Therapy for BK Virus Infection","volume":"90","author":"Liacini","year":"2010","journal-title":"Transplantation"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.3390\/v14081616","article-title":"BK Virus Nephropathy in Kidney Transplantation: A State-Of-The-Art Review","volume":"14","author":"Kant","year":"2022","journal-title":"Viruses"},{"key":"B7","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.xkme.2020.06.015","article-title":"Advances in BK Virus Complications in Organ Transplantation and beyond","volume":"2","author":"Cohen-Bucay","year":"2020","journal-title":"Kidney Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"329","DOI":"10.5500\/wjt.v7.i6.329","article-title":"Polyoma Virus Nephropathy in Kidney Transplantation","volume":"7","author":"Scadden","year":"2017","journal-title":"World J Transpl"},{"key":"B9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jcv.2018.10.002","article-title":"Risk Factors for BK Virus Viremia and Nephropathy after Kidney Transplantation: A Systematic Review","volume":"109","author":"Demey","year":"2018","journal-title":"J Clin Virol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2147\/ijnrd.s7044","article-title":"Role of Tacrolimus Combination Therapy with Mycophenolate Mofetil in the Prevention of Organ Rejection in Kidney Transplant Patients","volume":"3","author":"Dalal","year":"2010","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1097\/TP.0000000000001333","article-title":"BK Polyomavirus and the Transplanted Kidney: Immunopathology and Therapeutic Approaches","volume":"100","author":"Lamarche","year":"2016","journal-title":"Transplantation"},{"key":"B12","doi-asserted-by":"publisher","first-page":"6711","DOI":"10.1097\/JS9.0000000000001800","article-title":"Optimum Tacrolimus Trough Levels for Enhanced Graft Survival and Safety in Kidney Transplantation: A Retrospective Multicenter Real-World Evidence Study","volume":"110","author":"Han","year":"2024","journal-title":"Int J Surg"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e927420","DOI":"10.12659\/AOT.927420","article-title":"Acute Rejection and Infectious Complications in ABO- and HLA-Incompatible Kidney Transplantations","volume":"25","author":"Ko","year":"2020","journal-title":"Ann Transpl"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e13533","DOI":"10.1111\/ctr.13533","article-title":"The Results of HLA-Incompatible Kidney Transplantation According to Pre-transplant Crossmatch Tests: Donor-specific Antibody as a Prominent Predictor of Acute Rejection","volume":"33","author":"Kwon","year":"2019","journal-title":"Clin Transpl"},{"key":"B15","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/nep.13412","article-title":"Clinical Significance of Isoagglutinin Titre with the Current Desensitization Protocol in ABO-Incompatible Kidney Transplantation","volume":"24","author":"Baek","year":"2019","journal-title":"Nephrology (Carlton)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e13528","DOI":"10.1111\/ctr.13528","article-title":"BK Polyomavirus in Solid Organ Transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Hirsch","year":"2019","journal-title":"Clin Transpl"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1111\/j.1600-6143.2010.03310.x","article-title":"Reducing Immunosuppression Preserves Allograft Function in Presumptive and Definitive Polyomavirus-Associated Nephropathy","volume":"10","author":"Schaub","year":"2010","journal-title":"Am J Transpl"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1111\/j.1523-1755.2005.00602.x","article-title":"BK Virus Nephritis: Risk Factors, Timing, and Outcome in Renal Transplant Recipients","volume":"68","author":"Vasudev","year":"2005","journal-title":"Kidney Int"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1097\/TP.0b013e3181bca422","article-title":"Inhibition of Polyomavirus BK-specific T-Cell Responses by Immunosuppressive Drugs","volume":"88","author":"Egli","year":"2009","journal-title":"Transplantation"},{"key":"B20","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/j.1600-6143.2009.02834.x","article-title":"KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients","volume":"9","year":"2009","journal-title":"Am J Transpl"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1097\/TP.0000000000004976","article-title":"The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation","volume":"108","author":"Kotton","year":"2024","journal-title":"Transplantation"},{"key":"B22","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1600-6143.2005.00742.x","article-title":"Incidence of BK with Tacrolimus versus Cyclosporine and Impact of Preemptive Immunosuppression Reduction","volume":"5","author":"Brennan","year":"2005","journal-title":"Am J Transpl"},{"key":"B23","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.ajt.2024.11.019","article-title":"BK Polyomavirus Serotype-specific Antibody Responses in Blood Donors and Kidney Transplant Recipients with and without New-Onset BK Polyomavirus-DNAemia: A Swiss Transplant Cohort Study","volume":"25","author":"Hillenbrand","year":"2025","journal-title":"Am J Transpl"},{"key":"B24","doi-asserted-by":"publisher","first-page":"269","DOI":"10.5500\/wjt.v7.i5.269","article-title":"Graft Loss Among Renal-Transplant Recipients with Early Reduction of Immunosuppression for BK Viremia","volume":"7","author":"Azar","year":"2017","journal-title":"World J Transpl"},{"key":"B25","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1097\/TP.0b013e31826690c6","article-title":"Management and Outcome of BK Viremia in Renal Transplant Recipients: A Prospective Single-Center Study","volume":"94","author":"Sood","year":"2012","journal-title":"Transplantation"},{"key":"B26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1399-3062.2011.00619.x","article-title":"Monthly Screening for BK Viremia Is an Effective Strategy to Prevent BK Virus Nephropathy in Renal Transplant Recipients","volume":"13","author":"Alm\u00e9ras","year":"2011","journal-title":"Transpl Infect Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1600-6143.2009.02952.x","article-title":"BK-Virus and the Impact of Pre-emptive Immunosuppression Reduction: 5-year Results","volume":"10","author":"Hardinger","year":"2010","journal-title":"Am J Transpl"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e927367","DOI":"10.12659\/AJCR.927367","article-title":"Use of Leflunomide as an Antiviral Agent with Everolimus for BK Virus Nephropathy Patients after Kidney Transplantation: A Case Series","volume":"21","author":"Yamazaki","year":"2020","journal-title":"Am J Case Rep"},{"key":"B29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.15171\/jnp.2016.06","article-title":"Evaluation of Leflunomide for the Treatment of BK Viremia and Biopsy Proven BK Nephropathy; a Single Center Experience","volume":"5","author":"Nesselhauf","year":"2016","journal-title":"J Nephropathol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e14724","DOI":"10.1111\/petr.14724","article-title":"Leflunomide as Adjunct Therapy for BK Viremia Management in Pediatric Kidney Transplant Recipients","volume":"28","author":"Aldieri","year":"2024","journal-title":"Pediatr Transpl"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e13058","DOI":"10.1111\/tid.13058","article-title":"Clinical Utility of Leflunomide for BK Polyomavirus Associated Nephropathy in Kidney Transplant Recipients: A Multicenter Retrospective Study","volume":"21","author":"Keller","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"100565","DOI":"10.1016\/j.trre.2020.100565","article-title":"Leflunomide in the Treatment of BK Polyomavirus Associated Nephropathy in Kidney Transplanted Patients - A Systematic Review","volume":"34","author":"Schneidewind","year":"2020","journal-title":"Transpl Rev (Orlando)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/j.1432-2277.2007.00523.x","article-title":"Leflunomide Treatment for Polyomavirus BK-Associated Nephropathy after Kidney Transplantation","volume":"20","author":"Faguer","year":"2007","journal-title":"Transpl Int"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1093\/ndt\/gfy346","article-title":"Reducing Calcineurin Inhibitor First for Treating BK Polyomavirus Replication after Kidney Transplantation: Long-Term Outcomes","volume":"34","author":"Bischof","year":"2019","journal-title":"Nephrol Dial Transpl"},{"key":"B35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2147\/oajct.s63058","article-title":"TRANSFORM: A Novel Study Design to Evaluate the Effect of Everolimus on Long-Term Outcomes after Kidney Transplantation","volume":"6","author":"Pascual","year":"2014","journal-title":"Open Access J Clin Trials"},{"key":"B36","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/tid.12347","article-title":"Conversion to a Sirolimus-Based Regimen Is Associated with Lower Incidence of BK Viremia in Low-Risk Kidney Transplant Recipients","volume":"17","author":"Tohme","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.kint.2024.09.018","article-title":"Insights from the BKEVER Trial Comparing Everolimus versus Mycophenolate Mofetil for BK Polyomavirus Infection in Kidney Transplant Recipients","volume":"107","author":"Caillard","year":"2025","journal-title":"Kidney Int"},{"key":"B38","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/ajt.13541","article-title":"BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus through a Pathway Involving FKBP-12","volume":"16","author":"Hirsch","year":"2016","journal-title":"Am J Transpl"},{"key":"B39","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08155","article-title":"mTOR Regulates Memory CD8 T-Cell Differentiation","volume":"460","author":"Araki","year":"2009","journal-title":"Nature"},{"key":"B40","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/phar.2656","article-title":"Race and Sex Associations with Tacrolimus Pharmacokinetics in Stable Kidney Transplant Recipients","volume":"42","author":"Tornatore","year":"2022","journal-title":"Pharmacotherapy"},{"key":"B41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.genm.2011.01.003","article-title":"Gender Differences in Pharmacokinetics of Tacrolimus and Their Clinical Significance in Kidney Transplant Recipients","volume":"8","author":"Velickovi\u0107-Radovanovi\u0107","year":"2011","journal-title":"Gend Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/ndt\/gfaf002","article-title":"BK Polyomavirus-Associated Nephropathy - Diagnostic and Treatment Standard","volume":"40","author":"Al-Talib","year":"2025","journal-title":"Nephrol Dial Transpl"}],"container-title":["Transplant International"],"original-title":[],"link":[{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2025.14738\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T16:29:30Z","timestamp":1753288170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2025.14738\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":42,"alternative-id":["10.3389\/ti.2025.14738"],"URL":"https:\/\/doi.org\/10.3389\/ti.2025.14738","relation":{},"ISSN":["1432-2277"],"issn-type":[{"value":"1432-2277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]},"article-number":"14738"}}